期刊文献+

纳洛酮对急性重症非心源性脑梗死患者血浆BNP水平的影响 被引量:6

The effect of naloxone on plasma BNP level inpatients with severe acute non-cardiogenic cerebral infarction
下载PDF
导出
摘要 目的观察纳洛酮对急性重症非心源性脑梗死患者血浆BNP的影响,探讨其脑保护作用机制。方法将116例重症非心源性脑梗死患者(NIHSS≥8,GCS≤8分)随机分为治疗组(n=58)和对照组(n=58),对照组入院后给予常规治疗,治疗组在常规治疗的基础上给予盐酸纳洛酮静脉注射,分别于入院1、3、7d检测血浆BNP水平,同时进行NIHSS、GCS评分,根据脑水肿CT值判断脑水肿程度。结果 2组3d、7d时血浆BNP水平均明显增高,脑水肿较重,神经功能缺损严重,与对照组相比,治疗组血浆BNP水平下降,脑水肿、神经功能缺损程度均减轻(P<0.05)。结论纳洛酮可显著改善急性重症非心源性脑梗死神经功能缺损程度,减轻脑水肿,其神经保护作用可能与下调血浆BNP水平有关。 Objective To observe the effect of naloxone on plasma BNP level in patients with severe acute non-cardiogenic cerebral infarction (ANCCI) and to explore its protective mechanism.Methods We collected 116 cases with severe ANCCI (NIHSS≥8 scores,GCS ≤8 scores) in our study and randomly divided all cases into treatment group (n=58) and control group (n=58).Routine therapy was given for control group and combination of naloxone injection with routine therapy was given for treatment group.Plasma BNP level was detected on the 1st,3rd and 7th days and NIHSS and GCS were used to evaluate neurological function.Based on CT value we estimate the degree of brain edema.Results On the 3rd and 7th days the two groups showed high levels of plasma BNP,severe brain edema and serious neurological functional deficits.Compared with control group,treatment group presented lower level of BNP and less injury of brain edema and neurological function (P〈0.05).Conclusion Naloxone can effectively improve the degree of neurological functional deficits and relieve brain edema.Its neuroprotective effect may be associated with down-regulation of plasma BNP level.
出处 《中国实用神经疾病杂志》 2017年第12期39-41,共3页 Chinese Journal of Practical Nervous Diseases
关键词 纳洛酮 急性重症非心源性脑梗死 血浆BNP水平 NIHSS评分 GCS评分 Naloxone Severe acute non-cardiogenic cerebral infarction Plasma BNP level NIHSS scores GCS scores
  • 相关文献

参考文献5

二级参考文献45

  • 1陈忠,马根山,冯毅,严金川,罗丹.脑钠肽对早发急性心肌梗死患者近期预后的影响[J].中华急诊医学杂志,2006,15(2):164-167. 被引量:15
  • 2李运伟.纳洛酮治疗顽固性心衰的临床观察[J].中原医刊,2006,33(15):76-76. 被引量:2
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 4郑世良,刘瑜,王敏,崔洪伟.脑钠肽和内皮素对充血性心力衰竭诊断及预后判断的比较[J].中国急救医学,2007,27(7):596-598. 被引量:6
  • 5Pedram A, Razandi M, Hu RM, et al. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Bio Chem, 1997, 272: 17097- 17103.
  • 6Rubattu S, Stanzione R, Angelantionio e, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke, 2004, 35: 814-818.
  • 7Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis, 2002, 44: 293-321.
  • 8Melanson SE, Lewandrowski EL. Laboratory testing for B-type natriuretic peptides (BNP and NT-proBNP): clinical usefulness, utilization, and impact on hospital operations. Am J Clin Pathol, 2005, 124(Suppl): S122-S128.
  • 9Maldkallio AM, Makikallio TH, Korpelainen Jr, et al. Natriuretic peptides and Mortality after stroke. Stroke, 2005, 36: 1016-1020.
  • 10Takahashi K, totsune K, Sone M, et al. Human Brain natriuretic peptide-like immunoreactivity in human brain. Peptides, 1992, 13: 121-123.

共引文献64

同被引文献33

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部